View in EDS HTML Full Text PDF Full Text

An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.

Saved in:
Bibliographic Details
Title: An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.
Authors: Querol L; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain., Lewis RA; Cedars Sinai Medical Center, Los Angeles, California, USA., Hartung HP; Department of Neurology, Faculty of Medicine, Heinrich Heine University, Düsseldorf, Germany.; Brain and Mind Center, University of Sydney, Sydney, New South Wales, Australia.; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic., Van Doorn PA; Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Wallstroem E; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA., Luo X; Biostatistics and Programming, Sanofi R&D, Bridgewater, New Jersey, USA., Alonso-Alonso M; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA., Atassi N; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA., Hughes RAC; UCL Queen Square Institute of Neurology, University College London, London, UK.
Source: Journal of the peripheral nervous system : JPNS [J Peripher Nerv Syst] 2023 Jun; Vol. 28 (2), pp. 276-285. Date of Electronic Publication: 2023 May 31.
Publication Type: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 9704532 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-8027 (Electronic) Linking ISSN: 10859489 NLM ISO Abbreviation: J Peripher Nerv Syst Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37119056
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Querol+L%22">Querol L</searchLink>; Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.; Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lewis+RA%22">Lewis RA</searchLink>; Cedars Sinai Medical Center, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Hartung+HP%22">Hartung HP</searchLink>; Department of Neurology, Faculty of Medicine, Heinrich Heine University, Düsseldorf, Germany.; Brain and Mind Center, University of Sydney, Sydney, New South Wales, Australia.; Department of Neurology, Medical University of Vienna, Vienna, Austria.; Department of Neurology, Palacky University Olomouc, Olomouc, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Van+Doorn+PA%22">Van Doorn PA</searchLink>; Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Wallstroem+E%22">Wallstroem E</searchLink>; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Luo+X%22">Luo X</searchLink>; Biostatistics and Programming, Sanofi R&D, Bridgewater, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Alonso-Alonso+M%22">Alonso-Alonso M</searchLink>; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Atassi+N%22">Atassi N</searchLink>; Neurology Development, Sanofi R&D, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+RAC%22">Hughes RAC</searchLink>; UCL Queen Square Institute of Neurology, University College London, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229704532%22">Journal of the peripheral nervous system : JPNS</searchLink> [J Peripher Nerv Syst] 2023 Jun; Vol. 28 (2), pp. 276-285. <i>Date of Electronic Publication: </i>2023 May 31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9704532 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-8027 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210859489%22">10859489 </searchLink><i>NLM ISO Abbreviation: </i>J Peripher Nerv Syst <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37119056
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/jns.12551
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 276
    Titles:
      – TitleFull: An innovative phase 2 proof-of-concept trial design to evaluate SAR445088, a monoclonal antibody targeting complement C1s in chronic inflammatory demyelinating polyneuropathy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Querol L
      – PersonEntity:
          Name:
            NameFull: Lewis RA
      – PersonEntity:
          Name:
            NameFull: Hartung HP
      – PersonEntity:
          Name:
            NameFull: Van Doorn PA
      – PersonEntity:
          Name:
            NameFull: Wallstroem E
      – PersonEntity:
          Name:
            NameFull: Luo X
      – PersonEntity:
          Name:
            NameFull: Alonso-Alonso M
      – PersonEntity:
          Name:
            NameFull: Atassi N
      – PersonEntity:
          Name:
            NameFull: Hughes RAC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2023 Jun
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1529-8027
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of the peripheral nervous system : JPNS
              Type: main
ResultId 1